OpenLB
Open Library of Bioscience
Advanced Search

Journal

Publication Year

1 year 3 years 5 years 10 years
2021 - 2032
202120222023
202420252026
202720282029
203020312032
2021 - 2032
202120222023
202420252026
202720282029
203020312032

Publication Type

Associated Data

Found 25,064 results

Filters: population pharmacokinetics

[Population pharmacokinetics and its application in new drug research].
Wen-jun Chen, Tian-yan Zhou, Wei Lu
Yao Xue Xue Bao. Mar, 2017.52(3):371-7 Print
Source:PubMed
PMID: 29979556 doi:
How can polymyxin B be dosed based on current pharmacokinetic knowledge?
Huadong Chen, Zhenjiao Zhang, Zhenwei Yu
Eur J Clin Pharmacol. Sep, 2024.80(9):1421-1423 Print-Electronic
Source:PubMed
PMID: 38847855 doi:10.1007/s00228-024-03708-3
Population pharmacokinetics of duloxetine in Japanese pediatric patients with major depressive disorder.
Risa Yokokawa Shibata, Ryuji Kubota, Kazunori Uenaka, Atsunori Kaibara, Toshihiro Wajima
Drug Metab Pharmacokinet. Aug, 2023.51:100496 Print-Electronic
Source:PubMed
PMID: 37244205 doi:10.1016/j.dmpk.2023.100496
Pharmacokinetics of plasma-derived and recombinant factor IX: using population pharmacokinetics with sparse sampling data needs further study.
E Berntorp
Haemophilia. Nov, 2013.19(6):805-7 Print
Source:PubMed
PMID: 24165154 doi:10.1111/hae.12277
Guidance for industry on Population Pharmacokinetics; availability. Food and Drug Administration, HHS. Notice.
No authors listed
Fed Regist. Feb 10, 1999.64(27):6663-4 Print
Source:PubMed
PMID: 10557596 doi:
Population pharmacokinetics of mycophenolate in patients treated for interstitial lung disease (EVER-ILD study).
Yan-Min Xu, David Ternant, Martine Reynaud-Gaubert, Th��odora Bejan-Angoulvant, Sylvain Marchand-Adam
Fundam Clin Pharmacol. Oct, 2024.38(5):1008-1016 Print-Electronic
Source:PubMed
PMID: 38880975 doi:10.1111/fcp.13021
Integrated population pharmacokinetics of etanercept in healthy subjects and in patients with rheumatoid arthritis and ankylosing spondylitis.
Simon Y Zhou, Cathye Shu, Joan Korth-Bradley, Donald Raible, Maria Palmisano, Joseph Wadjula, Saeed Fatenejad, Thorir Bjornsson
J Clin Pharmacol. Jun, 2011.51(6):864-75 Print-Electronic
Source:PubMed
PMID: 20852002 doi:10.1177/0091270010375961
Comment on: "External Evaluation of Population Pharmacokinetic Models for Precision Dosing: Current State and Knowledge Gaps".
Meng Lv, Shengnan Zhang
Clin Pharmacokinet. 08, 2023.62(8):1183-1185 Print-Electronic
Source:PubMed
PMID: 37351794 doi:10.1007/s40262-023-01271-1
Population pharmacokinetics of doxorubicin: A systematic review.
Janthima Methaneethorn, Kanokkan Tengcharoen, Nattawut Leelakanok, Rowan AlEjielat
Asia Pac J Clin Oncol. Feb, 2023.19(1):9-26 Print-Electronic
Source:PubMed
PMID: 35415961 doi:10.1111/ajco.13776
The application of population pharmacokinetics to the drug development process.
K A Jackson, S E Rosenbaum
Drug Dev Ind Pharm. Dec, 1998.24(12):1155-62 Print
Source:PubMed
PMID: 9876572 doi:10.3109/03639049809108574
0